The current status of targeted radiotherapy in clinical practice

Physics in Medicine and Biology

Volumn 41, Issue 10, 1996, Pages 1895-1903

  Gaze, Mark N ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; IODINE; ION; STRONTIUM;

ARTICLE; BONE METABOLISM; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PRACTICE; IRRADIATION; NEUROBLASTOMA; PRIORITY JOURNAL; TUMOR CELL;

3-IODOBENZYLGUANIDINE; ADULT; BONE NEOPLASMS; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; IODOBENZENES; LEUKEMIA; LYMPHOMA; NEOPLASMS; NEUROBLASTOMA; OVARIAN NEOPLASMS; PALLIATIVE CARE; POLYCYTHEMIA; RADIOIMMUNOTHERAPY; RADIOTHERAPY; THYROID NEOPLASMS;

EID: 0029744662     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/41/10/003     Document Type: Article

References (49)

1. Bakri Y N and Given F T 1984 Radioactivity in blood and urine following intraperitoneal instillation of chromium phosphate in patients with and without ascites Am. J. Obstet. Gynaecol. 150 184-8
2. Baldwin R M 1986 Chemistry of radioiodine (Appl. Radiat. Isot.) Int. J. Radiat. Appl. Instrum. 37 817-21
3. Beierwaltes W H 1987 Update on basic research and clinical experience with meta-iodobenzylguanidine Med. Pediatr. Oncol. 15 163-9
4. Beierwaltes W H, Nishiyama R H, Thompson N W, Copp J E and Kubo A 1982 Survival lime and 'cure' in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J. Nucl. Med. 23 561-8
5. Blake G M, Zivanovic M A, Blaquiere R M, Fine D R, McEwan A J and Ackery D M 1988 Strontium-89 therapy: measurement of absorbed dose to skeletal metastases J. Nucl. Med. 29 549-57
6. Blake G M, Zivanovic M A, McEwan A J and Ackery D M 1986 Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostate Eur. J. Nucl. Med. 12 447-54
7. Coakham H B, Richardson R B, Bourne S, Davies A G and Kemshead J T 1985 Antibody-guided radiolocalisation and therapy for neoplastic meningitis Br. J. Cancer 52 655
8. 131I-mIBG and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma J. Nucl. Biol. Med. 21 1587-94
9. Courtenay-Luck N S, Epenetos A A, Moore R 1986 Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms Cancer Res. 46 6489-93
10. Dearnaley D P, Bayly R J, A'Hern R P, Gadd J, Zivanovic M M and Lewington V J 1992 Palliation of bone metastases in prostate cancer: hemibody irradiation or strontium-89? Clin. Oncol. 4 101-7
11. de Kraker J, Hoefnagel C A, Caron H, Valdés Olmos R A, Zsiros J, Heij H A and Voûte P A 1995 First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma Eur. J. Cancer A 31 600-2
12. 131I-Lym-1 and mechanisms for improvement Monoclonal Antibodies 2: Applications in Clinical Oncology ed A A Epenetos (London: Chapman and Hall) pp 355-67
13. Dencker L, Larsson B, Olander K and Ullberg S 1982 A new melanoma seeker for possible clinical use: selective accumulation of radiolabelled thiouracil Br. J. Cancer 45 95-104
14. Erlich P 1960 Chemotherapy The Collected Papers of Paul Erlich ed P Erlich (New York: Pergamon) pp 505-18
15. Garaventa A, Guerra P, Arrighini A, Bertolazzi L, Bestagno M, de Bernadi B, Lanino E, Villavecchia G P and Claudiani F 1991 Treatment of advanced neuroblastoma with I-131 meta-iodobenzylguanidine Cancer 67 922-8
16. Gaze M N and Wheldon T E 1996 Radiolabelled mIBG in treatment of neuroblastoma Eur. J. Cancer 32A 93-6
17. 131I]meta-iodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: feasibility study of a new strategy for advanced neuroblastoma Eur. J. Cancer A 31 252-6
18. 131I-meta iodobenzylguanidine Br. J. Radiol. 60 393-5
19. Harvey Turner J, Martindale A, Sorby P, Hetherington E, Fleay R, Hoffman R and Caringbold P 1989 Samarium-153 EDTMP therapy of disseminated skeletal metastases Eur. J. Nucl. Med. 15 784-95
20. Hoefnagel C A, Voûte P A, de Kraker J and Marcuse H R 1987 Radionuclide diagnosis and therapy of neural crest tumours using iodine-131 metaiodobenzylguanidine J. Nucl. Med. 28 308-14
21. Hoskin P, Ford H T and Harmer C L 1989 Hemibody irradiation (HBI) for metastatic bone pain in two histologically distinct groups of patients Clin. Oncol. 1 67-9
22. Kemshead J T, Lashford L S, Jones D H and Coakham H B 1987 Diagnosis and therapy of neuroectodermally associated tumours using targeted radiation Dev. Neurosc. 9 69-83
23. 131I-m]IBG Advances in Neuroblastoma Research 4 ed A E Evans, J L Biedler, G M Brodeur, G J D'Angio and A Nakagawara (New York: Wiley-Liss) pp 309-17
24. Köhler G and Milstein C 1975 Continuous cultures of fused cells secreting antibody of predefined specificity Nature 256 495-7
25. 131I mIBG Radio. Oncol. 17 103-8
26. Lashford L S, Lewis I J, Fielding S L 1992 Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigation J. Clin. Oncol. 10 1889-96
27. 90Y-labeled antiferritin in hepatoma Int. J. Radiat. Oncol. Biol. Phys. 14 1033-42
28. Lenhard R E, Order C E, Spunberg J J, Asbell S O and Liebel S A 1985 Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease. J. Clin. Oncol. 3 1296-300
29. Lewington V J, McEwan A J, Ackery D M, Bayley R J, Keeling D H, Macleod P M, Porter A T and Zivanovic M A 1991 A prospective randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone Eur. J. Cancer 27 954-8
30. 211At-methylene blue for pigmented melanoma in an animal model system Cancer Res. 4 4332-7
31. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases Cancer Res. 50 2963-7
32. 131I-labelled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation Blood at press
33. Najean Y, Triebel F and Dresch C 1980 P-32 therapy of polycythaemia: a review and reappraisal Clin. Nucl. Med. 5 275-80
34. Olander K, Larsson B and Dencker L 1983 Thioamides as false melanin precursors: studies in murine melanomas Acta Pharmacol. Toxicol. 52 135-42
35. Order S E 1990 Systemic radiotherapy: the new frontier Int. J. Radiat. Oncol. Biol. Phys. 18 981-92
36. Order S E, Stillwagon G B and Klein J L 1985 Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study Jour. Clin. Oncol. 3 1573-82
37. Pervez S, Kirkland S C, Epenetos A A, Mooi W J, Evans D J and Krausz T 1989 Effect of polarity and differentiation on antibody localisation in multicellular tumour spheroid and xenograft models and its potential importance for in vitro immunotargeting Int. J. Cancer 44 940-7
38. Pizer B, Papanastassiou V, Hancock J, Cassano W, Coakham H and Kemshead J 1991 A pilot study of monoclonal antibody targeted radiotherapy in the treatment of central nervous system leukaemia in children Br. J. Haematol. 77 466-72
39. Porter A T, McEwan A J B, Powe J E, Reid R, McGowan D G, Lukka H, Sathyanarayana J R, Yakemchuk V N, Thomas G M, Erlich L E, Crook J, Gulenchyn K Y, Hong K E, Wesolowski C and Yardley J 1993 Results of a randomised phase III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 25 805-13
40. Press O W, Eary J F, Appelbaum F R, Martin P J, Badger C C, Nelp W B, Glenn S, Butchko G, Fisher D, Porter B, Matthews D C, Fisher L D and Bernstein I D 1993 Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support New Eng. J. Med. 329 1219-24
41. Quilty P M, Kirk D, Bolger J J, Dearnley D P, Lewington V J, Mason M D, Reed N S E, Russell J M and Yardley J 1994 A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer Radiother. Oncol. 31 33-40
42. Shapiro B, Copp J E, Sisson J C, Eyre P L, Wallis J and Beierwaltes W H 1985 Iodine-131 meta-iodobenzylguanidine for the locating of suspected phaeochromocytoma: experience in 400 cases J. Nucl. Med. 26 576-85
43. Sisson J C, Shapiro B, Beierwaltes W H, Glowniak J V, Nakajo M, Mangner T J, Carey J E, Swanson D P, Copp J E, Satterlee W G and Wieland D M 1984 Radiopharmaceutical treatment of malignant phaeochromocytoma J. Nucl. Med. 24 197-206
44. Stewart J S W, Hird V and Snook D 1989 Intraperitoneal radioimmunotherapy for ovarian cancer: pharmacokinetics, toxicity and efficacy of I-131 labeled monoclonal antibodies Int. J. Radiat. Oncol. Biol. Phys. 16 405-13
45. 131I] iodobenzylguanidine Lancet i 333-4
46. 131I-meta-iodobenzylguanidine in patients with neuroblastoma. Future prospects of zetotherapy Advances in Neuroblastoma Research 3 eds A E Evans, G J D'Angio, A G Knudson and R C Seeger (New York: Wiley-Liss) pp 439-45
47. Vriesendorp H M, Herpst J M, Leichner P K, Klein J L and Order S E 1989 Polyclonal 90 yttrium labelled antiferritin for refractory Hodgkin's disease Int. J. Radiat. Oncol. Biol. Phys. 17 815-21
48. Wahl R L 1990 Radiolabelled monoclonal antibodies for the diagnosis and treatment of ovarian cancer The Present and Future Role of Monoclonal Antibodies in the Management of Cancer ed J M Vaeth and J L Meyer (Basel: Karger) pp 228-39
49. Wätjen F, Buchardt O and Langvad E 1982 Affinity therapeutics. 1. Selective incorporation of 2-thiouracil derivatives in murine melanomas. Cytostatic activity of 2-thiouracil arotinoids, 2-thiouracil retinoids, arotinoids and retinoids J. Med. Chem. 25 956-60